| 000 | 00820 a2200217 4500 | ||
|---|---|---|---|
| 005 | 20250517223638.0 | ||
| 264 | 0 | _c20190913 | |
| 008 | 201909s 0 0 eng d | ||
| 022 | _a1551-4005 | ||
| 024 | 7 |
_a10.1080/15384101.2018.1491459 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSkowronska-Krawczyk, Dorota | |
| 245 | 0 | 0 |
_aMarking cell-type-restricted enhancers before their activation. _h[electronic resource] |
| 260 |
_bCell cycle (Georgetown, Tex.) _c2018 |
||
| 300 |
_a1525-1526 p. _bdigital |
||
| 500 | _aPublication Type: Editorial; Comment | ||
| 650 | 0 | 4 | _aEmbryonic Stem Cells |
| 650 | 0 | 4 | _aEnhancer Elements, Genetic |
| 773 | 0 |
_tCell cycle (Georgetown, Tex.) _gvol. 17 _gno. 13 _gp. 1525-1526 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1080/15384101.2018.1491459 _zAvailable from publisher's website |
| 999 |
_c28556575 _d28556575 |
||